valvular heart disease
Recently Published Documents


TOTAL DOCUMENTS

2275
(FIVE YEARS 438)

H-INDEX

78
(FIVE YEARS 7)

Author(s):  
Friedhelm Beyersdorf ◽  
Alec Vahanian ◽  
Milan Milojevic ◽  
Fabien Praz ◽  
Stephan Baldus ◽  
...  

2022 ◽  
Vol 6 (1) ◽  
pp. 01-06
Author(s):  
Khin Phyu Pyar ◽  
Sai Aik Hla ◽  
Win Myint ◽  
Win Kyaw Shwe ◽  
Soe Win Hlaing ◽  
...  

A 58 year old man was brought to hospital in state of deep coma following severe headache for one day. His GCS was 3/15 and had flaccid all 4 limbs with equivocal planter response on both sides on arrival. NECT head showed acute subdural haemorrhage with surrounding cerebral oedema, mid-line shift and corning of brain stem. After giving mannitol and dexamethasone, four hours later, he became fully conscious and orientated; his motor power returned to normal. He was on warfarin 3mg daily for rheumatic mitral valvular heart disease with atrial fibrillation and his INR on arrival was 3.5. He had intractable hiccups once he regained consciousness. Both pharmacological and non-pharmacological measures were tried for distressing hiccups; there was no therapeutic success. His hiccups disappeared completely only after removing the haematoma by burr hole surgery.


Author(s):  
Aykan Yucel ◽  
Zuhal Koksal ◽  
Tugba Ensari ◽  
Atakan Tanacan ◽  
Orhan Altinboga ◽  
...  

2022 ◽  
pp. 181-190
Author(s):  
Nathan H. Waldron ◽  
Martin I. Sigurdsson ◽  
Joseph P. Mathew

2022 ◽  
pp. 527-571
Author(s):  
Feridoun Noohi ◽  
Anita Sadeghpour ◽  
Azin Alizadehasl

Author(s):  
Linwen Zhu ◽  
Zhifang Wang ◽  
Lebo Sun ◽  
Dawei Zheng ◽  
Bingchuan Hu ◽  
...  

Author(s):  
Tiphaine Leblon ◽  
Clemence Riolet ◽  
Pierre Vladimir Ennezat ◽  
Sylvestre Marechaux

Abstract Background Drug-induced valvular heart disease (DI-VHD) is a well-defined condition associated with specific pathology features. However, clinical presentations may broadly vary and thereby make DI-VHD diagnosis more challenging. Case summary We report two patients with a history of benfluorex administration, who developed extensive mitral calcific lesions which evolved towards caseous necrosis. Discussion Prospective follow-up over several years of these two patients who initially had typical DI-VHD findings provided monitoring evidence of extensive calcifications and subsequent caseous necrosis. These reports suggest a link between calcific heart injury and benfluorex exposure. The diagnosis of DI-VHD may be overlooked at this late stage.


2021 ◽  
Vol 8 ◽  
Author(s):  
Januar Wibawa Martha ◽  
Raymond Pranata ◽  
Wilson Matthew Raffaelo ◽  
Arief Wibowo ◽  
Mohammad Rizki Akbar

Purpose: There is uncertainty as to which anticoagulant should be used in non-valvular atrial fibrillation (AF) with valvular heart disease. This systematic review and meta-analysis aimed to assess the efficacy and safety of direct-acting oral anticoagulants (DOACs) compared with warfarin in patients with non-valvular AF with valvular heart disease.Methods: We performed a comprehensive literature search using PubMed, Scopus, Embase, and Clinicaltrials.gov from the inception of databases up until August 2, 2021, and the search was updated and finalized on October 17, 2021. The intervention group was DOACs and the control group was warfarin. The primary outcome was systemic embolism and stroke (SSE), and the secondary outcome was major bleeding and intracranial hemorrhage. The pooled effect estimate was reported as the hazard ratio (HR) and odds ratio (OR).Results: There were 21,185 patients from seven studies included in this systematic review and meta-analysis. Stroke and systemic embolism were lower in patients receiving DOACs [HR 0.76 (95% CI 0.67, 0.87), p < 0.001; I2: 5%] compared with warfarin. The subgroup analysis on RCTs showed the significant reduction of SSE in the DOACs group [HR 0.73 (95% CI 0.60, 0.89), p = 0.002; I2: 16%]. There was no significant difference in terms of major bleeding [HR 0.89 (95% CI 0.75, 1.05), p = 0.18; I2: 69%]. Intracranial hemorrhage [HR 0.42 (95% CI 0.22, 0.80), p = 0.008; I2: 73%] were lower in the DOAC group.Conclusion: This meta-analysis indicates that DOACs were associated with a lower risk of SSE and intracranial hemorrhage compared with patients receiving warfarin. There was no significant difference between the two groups in terms of major bleeding.


Sign in / Sign up

Export Citation Format

Share Document